Treatment of nosocomial pneumonia and tracheobronchitis caused by multidrug-resistant Pseudomonas aeruginosa with aerosolized colistin

American Journal of Respiratory and Critical Care Medicine

Volumn 162, Issue 1, 2000, Pages 328-330

  Hamer, Davidson H ^a  

^a TUFTS MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

COLISTIN;

ADULT; AEROSOL; AGED; ARTICLE; BRONCHITIS; CASE REPORT; DRUG EFFICACY; DRUG TOLERABILITY; HOSPITAL INFECTION; HUMAN; MALE; MULTIDRUG RESISTANCE; NEBULIZER; PNEUMONIA; PRIORITY JOURNAL; PSEUDOMONAS AERUGINOSA;

EID: 0033909658     PISSN: 1073449X     EISSN: None     Source Type: Journal    
DOI: 10.1164/ajrccm.162.1.9910071     Document Type: Article

References (12)

1. 1. National Nosocomial Infections Surveillance (NNIS) System. 1996. National Nosocomial Infections Surveillance report, data summary from October 1986-April 1996, issued May 1996. Am. J. Infect. Control 24: 380-388.
2. 2. Carmeli, Y., N. Troillet, A. W. Karchmer, and M. H. Samore. 1999. Health and economic outcomes of antibiotic resistance in Pseudomonas aeruginosa. Arch. Intern. Med. 159:1127-1132.
3. 3. Catchpole, C. R., J. M. Andrews, N. Brenwald, and R. Wise. 1997. A reassessment of the in-vitro activity of colistin sulphomethate sodium. J. Antimicrob. Chemother. 39:255-260.
4. 4. Sande, M. A., and G. L. Mandell. 1993. Antimicrobial agents: tetracyclines, chlorampenicol, erythromycin, and miscellaneous antibacterial agents. In A. G. Gilman, T. W. Rall, A. S. Nies, and P. Taylor, editors. The Pharmacological Basis of Therapeutics, 8th ed. McGraw-Hill, New York. 1117-1145.
5. 5. Valerius, N. H., C. Koch, and N. Hoiby. 1991. Prevention of chronic Pseudomonas aeruginosa colonisation in cystic fibrosis by early treatment. Lancet 338:725-726.
6. 6. Littlewood, J. M., M. G. Miller, A. T. Ghoneim, and C. H. Ramsden. 1985. Nebulised colimycin for early Pseudomonas colonisation in cystic fibrosis. Lancet i:865.
7. 7. Jensen, T., S. S. Pedersen, S. Garne, C. Heilmann, N. Hoiby, and C. Koch. 1987. Colistin inhalation therapy in cystic fibrosis patients with chronic Pseudomonas aeruginosa lung infection. J. Antimicrobial. Chemother. 19:831-838.
8. 8. Zylberberg, H., J. Vargaftig, C. Barbieux, N. Pertuiset, C. Rothschild, and J. P. Viard. 1996. Prolonged efficacy of secondary prophylaxis with colistin aerosols for respiratory infection due to Pseudomonas aeruginosa in patients infected with human immunodeficiency virus. Clin. Infect. Dis. 23:641-643.
9. 9. Green, S. T., D. Nathwani, Y. Gourlay, J. McMenamin, D. J. Goldberg, and D. H. Kennedy. 1992. Nebulized colistin (polymyxin E) for AIDS-associated Pseudomonas aeruginosa pneumonia. Int. J. STD AIDS 3: 130-131.
10. 10. Rello, J., D. Marisal, F. March, P. Jubert, F. Sanchez, J. Valles, and P. Coll. 1998. Recurrent Pseudomonas aeruginosa pneumonia in ventilated patients: relapse or reinfection? Am. J. Respir. Crit. Care Med. 157:912-916.
11. 11. Maddison, J., M. Dodd, and A. K. Webb. 1994. Nebulized colistin causes chest tightness in adults with cystic fibrosis. Respir. Med. 88:145-147.
12. 12. Levin, A. S., A. A. Barone, J. Penço. M. V. Santos, I. S. Marinho, E. A. G. Arruda, E. I. Manrique, and S. F. Costa. 1999. Intravenous colistin as therapy for nosocomial infections caused by multidrug-resistant Pseudomonas aeruginosa and Acinetobacter baumannii. Clin. Infect. Dis. 28:1008-1011.